Recent Articles
-
April 04, 2024 Commentary
Abstract A 29-year-old male underwent incidental detection of ostium secundum Atrial Septal Defect (ASD) with moderate pulmonary hypertension
-
January 24, 2024 Research Article
Abstract Fostamatinib is a tyrosine kinase inhibitor that has been shown in clinical trials to be effective against spleen tyrosine kinase in patients suffering from rheumatoid arthritis. Fostamatinib medication was linked in clinical trials to a slight incre.....
